2[45]Popov Y,Patsenker E,Bauer M,Niedobitek E,Schulze-Krebs A,Schuppan D.Halofuginone induces matrix metalloproteinases in rat hepatic stellate cells via activation of p38 and NFkappaB.J Biol Chem 2006; 281:15090-15098
3[46]Laleman W,Vander Elst I,Zeegers M,Servaes R,Libbrecht L,Roskams T,Fevery J,Nevens F.A stable model of cirrhotic portal hypertension in the rat:thioacetamide revisited.Eur J Clin Invest 2006; 36:242-249
4[47]Yeh CN,Maitra A,Lee KF,Jan YY,Chen MF.Thioacetamideinduced intestinal-type cholangiocarcinoma in rat:an animal model recapitulating the multi-stage progression of human cholangiocarcinoma.Carcinogenesis 2004; 25:631-636
5[48]Veal N,Oberti F,Moal F,Vuillemin E,Fort J,Kaassis M,Pilette C,Cales P.Spleno-renal shunt blood flow is an accurate index of collateral circulation in different models of portal hypertension and after pharmacological changes in rats.J Hepatol 2000; 32:434-440
7[50]Jenkins SA,Grandison A,Baxter JN,Day DW,Taylor I,Shields R.A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat.J Hepatol 1985; 1:489-499
8[51]Nanji AA.Animal models of nonalcoholic fatty liver disease and steatohepatitis.Clin Liver Dis 2004; 8:559-874,ix
9[52]DeLeve LD,McCuskey RS,Wang X,Hu L,McCuskey MK,Epstein RB,Kanel GC.Characterization of a reproducible rat model of hepatic veno-occlusive disease.Hepatology 1999; 29:1779-1791
10[53]Sweat ER,Musicant ME,Annetts DL,Goodhead B,Orloff MJ.Production of hepatic outflow block and ascites with an ameroid constrictor.Surg Forum 1966; 17:376-378
